Predictive Oncology Reports Positive Results Utilizing Artificial Intelligence for Drug Repurposing

Company successfully identified several abandoned or discontinued drugs for further testing and development in ovarian and other cancer types

Creates significant business development opportunities with meaningful long-term commercial potential with large pharmaceutical companies

Read more at globenewswire.com